Literature DB >> 23750604

Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells.

N H R Litjens1, E A de Wit, C C Baan, M G H Betjes.   

Abstract

Detection and isolation of viable alloreactive T cells at the single-cell level requires a cell surface marker induced specifically upon T cell receptor activation. In this study, a member of the tumour necrosis factor receptor (TNFR)-family, CD137 (4-1BB) was investigated for its potential to identify the total pool of circulating alloreactive T cells. Optimal conditions for sensitive and specific detection of allogeneic-induced CD137 expression on circulating T cells were established. Thereafter, CD137(+) alloreactive T cells were phenotypically and functionally characterized by multi-parameter flow cytometry. Alloantigen-induced CD137 expression identified both alloreactive CD8(+) T cells (mean ± standard error of the mean: 0·21 ± 0·07%) and alloreactive CD4(+) T cells (0·21 ± 0·05%). CD137(+) alloreactive T cells were detected in different T cell subsets, including naive T cells, but were found preferentially in CD28(+) T cells and not in the terminally differentiated T cell subset. Upon allogeneic (re-)stimulation, the cytokine-producing as well as proliferative capacity of T cells resided mainly within the CD137-expressing fraction. About 10% of the CD137(+) alloreactive T cells produced any combination of interferon (IFN)-γ, interleukin (IL)-2 and TNF-α. Polyfunctional alloreactive T cells, defined by multiple cytokine expression, were observed infrequently. In conclusion, activation-induced CD137 expression is a fast assay allowing for detection and functional analysis of the total alloreactive T cell compartment at the single-cell level by multi-parameter flow cytometry.
© 2013 British Society for Immunology.

Entities:  

Keywords:  CD137; CD4+ T cells; CD8+ T cells; alloreactivity; multi-parameter analysis

Mesh:

Substances:

Year:  2013        PMID: 23750604      PMCID: PMC3784225          DOI: 10.1111/cei.12152

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  Insights into the specificity and function of (allo)antigen-reactive T cells.

Authors:  H D Volk; F Kern
Journal:  Am J Transplant       Date:  2001-07       Impact factor: 8.086

Review 2.  Cellular methods used to evaluate the immune response in transplantation.

Authors:  N L Reinsmoen
Journal:  Tissue Antigens       Date:  2002-04

3.  Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro.

Authors:  Natalia Nikolaeva; Elena Uss; Ester M M van Leeuwen; René A W van Lier; Ineke J M ten Berge
Journal:  Transplantation       Date:  2004-09-27       Impact factor: 4.939

4.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

5.  Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells.

Authors:  L E Nomura; J M Walker; H T Maecker
Journal:  Cytometry       Date:  2000-05-01

6.  The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens.

Authors:  Nicole M van Besouw; Lenard M B Vaessen; Joke M Zuijderwijk; Marleen van Vliet; Jan N M IJzermans; Peter H van Der Meide; Willem Weimar
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

7.  Premature aging of circulating T cells in patients with end-stage renal disease.

Authors:  Michiel G H Betjes; Anton W Langerak; Ashley van der Spek; Elly A de Wit; Nicolle H R Litjens
Journal:  Kidney Int       Date:  2011-04-27       Impact factor: 10.612

Review 8.  Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities.

Authors:  Matthias Wölfl; Jürgen Kuball; Matthias Eyrich; Paul G Schlegel; Philip D Greenberg
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

9.  The human alloreactive CD4+ T-cell repertoire is biased to a Th17 response and the frequency is inversely related to the number of HLA class II mismatches.

Authors:  Nicolle H R Litjens; Jacqueline van de Wetering; Nicole M van Besouw; Michiel G H Betjes
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

10.  Frequency of human alloantigen-reactive T lymphocytes. II. Method for limiting dilution analysis of alloantigen-reactive helper T cells in human peripheral blood.

Authors:  C G Orosz; P W Adams; R M Ferguson
Journal:  Transplantation       Date:  1987-05       Impact factor: 4.939

View more
  25 in total

1.  p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.

Authors:  Nicola R Hardwick; Paul Frankel; Christopher Ruel; Julie Kilpatrick; Weimin Tsai; Ferdynand Kos; Teodora Kaltcheva; Lucille Leong; Robert Morgan; Vincent Chung; Raechelle Tinsley; Melissa Eng; Sharon Wilczynski; Joshua D I Ellenhorn; Don J Diamond; Mihaela Cristea
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

2.  p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses.

Authors:  Nicola R Hardwick; Mary Carroll; Teodora Kaltcheva; Dajun Qian; Dean Lim; Lucille Leong; Peiguo Chu; Joseph Kim; Joseph Chao; Marwan Fakih; Yun Yen; Jonathan Espenschied; Joshua D I Ellenhorn; Don J Diamond; Vincent Chung
Journal:  Clin Cancer Res       Date:  2014-07-01       Impact factor: 12.531

3.  Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood.

Authors:  Hanchih Wu; Ashley Witzl; Hideki Ueno
Journal:  Blood Adv       Date:  2019-07-23

4.  Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response.

Authors:  Liran Levy; Inbal Mishalian; Rachel Bayuch; Lida Zolotarov; Janna Michaeli; Zvi G Fridlender
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 5.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

6.  T and B Cell Composition and Cytokine Producing Capacity Before and After Bariatric Surgery.

Authors:  L H Wijngaarden; A E Taselaar; F Nuijten; E van der Harst; R A Klaassen; T M Kuijper; F Jongbloed; G Ambagtsheer; M Klepper; J N M IJzermans; R W F de Bruin; N H R Litjens
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 7.  Immune monitoring as prerequisite for transplantation tolerance trials.

Authors:  K Behnam Sani; B Sawitzki
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

8.  Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients.

Authors:  Jaap Kwekkeboom; Nicolle H R Litjens; Aafke A Duizendstra; Robert J de Knegt; Shanta Mancham; Mariska Klepper; Dave L Roelen; Simone H Brand-Schaaf; Patrick P Boor; Michail Doukas; Robert A de Man; Dave Sprengers; Maikel P Peppelenbosch; Michiel G H Betjes
Journal:  Liver Transpl       Date:  2021-07-21       Impact factor: 6.112

9.  Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish.

Authors:  Finola E Moore; Elaine G Garcia; Riadh Lobbardi; Esha Jain; Qin Tang; John C Moore; Mauricio Cortes; Aleksey Molodtsov; Melissa Kasheta; Christina C Luo; Amaris J Garcia; Ravi Mylvaganam; Jeffrey A Yoder; Jessica S Blackburn; Ruslan I Sadreyev; Craig J Ceol; Trista E North; David M Langenau
Journal:  J Exp Med       Date:  2016-05-02       Impact factor: 14.307

10.  Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation.

Authors:  Burç Dedeoglu; Ruud W J Meijers; Mariska Klepper; Dennis A Hesselink; Carla C Baan; Nicolle H R Litjens; Michiel G H Betjes
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.